Notice: Users may be experiencing issues with displaying some pages on stanfordhealthcare.org. We are working closely with our technical teams to resolve the issue as quickly as possible. Thank you for your patience.
New to MyHealth?
Manage Your Care From Anywhere.
Access your health information from any device with MyHealth. You can message your clinic, view lab results, schedule an appointment, and pay your bill.
ALREADY HAVE AN ACCESS CODE?
DON'T HAVE AN ACCESS CODE?
NEED MORE DETAILS?
MyHealth for Mobile
Use of Nintedanib for the Treatment of Systemic Sclerosis-associated Interstitial Lung Disease at Expert Scleroderma Centers in the United States.
Use of Nintedanib for the Treatment of Systemic Sclerosis-associated Interstitial Lung Disease at Expert Scleroderma Centers in the United States. Annals of the American Thoracic Society Luo, Y., Assassi, S., Mayes, M. D., Frech, T. M., Steen, V. D., Richardson, C., Chung, L., Sandorfi, N., VanBuren, J. M., Harding, M., Alvey, J. S., Skaug, B., McMahan, Z., Lakin, K. S., Zahn, C., Bracken, S. J., Lebiedz-Odrobina, D. J., Molitor, J. A., Evnin, L. B., Moore, D. F., Shah, A., Castelino, F. V., Volkmann, E. R., Hant, F. N., Makol, A., Shah, A. A., Hummers, L. K., Gordon, J. K., Khanna, D., Bernstein, E. J. 2025View details for DOI 10.1513/AnnalsATS.202410-1045RL
View details for PubMedID 40208257